Advertisement

Drugs

, Volume 51, Issue 6, pp 981–981 | Cite as

Ebrotidine

A Viewpoint by Stanislaw J. Konturek
  • Stanislaw J. Konturek
New Drug Profile Guest Commentary

Keywords

Nitric Oxide Adis International Limited Ranitidine Pylorus Infection Reflux Oesophagitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Konturek SJ, Kwiecien N, Sito E, et al. Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans. Scand J Gastroenterol 1993 Dec; 28: 1047–50PubMedCrossRefGoogle Scholar
  2. 2.
    Konturek SJ, Maczka J, Kaminski K, et al. Gastroprotective and antisecretory effects of ebrotidine. Scand J Gastroenterol 1992 Jun; 27 (6): 438–32PubMedCrossRefGoogle Scholar
  3. 3.
    Konturek SJ, Kwiecien N, Obtulowicz W, et al. Comparison of gastroprotective and inhibitory activities of ebrotidine and ranitidine in humans [abstract]. Gastroenterology 1994 Apr; 106 Suppl.: A111Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Stanislaw J. Konturek
    • 1
  1. 1.Institute of PhysiologyJagiellonian University School of MedicineKrakowPoland

Personalised recommendations